Biopharmadispatch

Who really holds the power? This week we discuss the interplay between advisory committees and government, and who's really in charge. Listen to the full episode: https://pharmadispatch.com/news/the-week-in-review-podcast-23-february #Government #PBS #PBAC #MSAC #AustralianGovernment #Medicare #HealthcareIndustry

Did you know the government is considering changes to accessing new health technologies? We have read the Health Technology Assessment Policy and Methods Review so you don’t have to: https://pharmadispatch.com/ It’s important everyone has their say on the proposed changes before Friday 23 February. Government and its officials need to be reminded our public health programs must serve Australian patients. Email [email protected] before it closes on 23 Feb 2024.

📢 Attention, Australians! Did you know you could be facing a massive change in what treatments and medicines you have access to? The Australian government has released an options paper which includes a raft of changes that would take Australia towards a system where patients would be denied access some new medicines and treatments. AND you only have until Friday 23 February submit your feedback. The proposed changes echo aspects of the healthcare system in New Zealand, which some are seeking to avoid by coming to Australia for treatment. Make Your Voice Heard Before It's Too Late! 🕒 #MedicalRefugee #Healthcare #Government #HealthcareSystems #OptionsPaper #TreatmentOptions

Should we be celebrating the outcomes of the latest Health Technology Assessment (HTA) review? Paul Cross and Felicity McNeill discuss. Listen to the full episode here: https://pharmadispatch.com/news/the-week-in-review-podcast-2-february #AustralianGovernment #Value #Medicines #Budget #KeyOutcomes #Patients #Hospital

How much actual growth has there been in federal government investment in F1 medicines? Read the full article: https://pharmadispatch.com/news/actual-growth-could-around-one-quarter-of-the-top-line-number #GovernmentSpending #FederalGovernment #Growth #Spending #AustralianGovernment #News #Pharma #Healthcare #Covid #Prescription

This week, we break down what you need to know about the annual PBS Expenditure and Prescriptions report, click here to subscribe and read the full story: https://pharmadispatch.com/news/the-individual-numbers-are-meaningless-but-they-still-tell-a-sto #News #Pharma #AustralianGovernment #Australia #PBS #Policy #HealthPolicy #AnnualReport #PublicHealth #Healthcare

Are you amongst the three-quarters of Australian's skipping appointments due rising costs? Subscribe and read more on the worrying data and lack of government action: https://pharmadispatch.com/news/data-we-have-been-collecting-for-the-past-three-years-is-now-pre #News #Pharma #Inflation #Health #Medical #Australia #Sydney #Hospital #Melbourne #Economy #Reform #Government #Medicare #BulkBilling

To mark the end of the year, Paul Cross and Felicity McNeill discuss the good, the bad and the ugly in healthcare and government across 2023. Kate Holliday, CEO, CCDR, is definitely one of the goods this year - listen to the full episode: https://pharmadispatch.com/news/the-end-of-year-review-podcast-19-december #2023RoundUp #CCDR #BioPharmaDispatch #Pharma #PharmaNews #Government #AusPol #ParliamentHouse #Medical #Health #Business